A Transversal Study for the French Validation of Two Assessment Tools of Gambling Related Cognitions.
NCT ID: NCT01219426
Last Updated: 2011-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
2008-03-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing and Testing a Brief Intervention for Problem Gambling in Credit Counseling
NCT04064749
Integrative Couple Treatment for Pathological Gambling
NCT02240485
Impact/Interest of a Collective Prevention Intervention in Sexual and Emotional Health
NCT06400758
Quantitative Study of Prevalence and Vulnerability Factors of Active Cyber Sexuality Among Teenagers in West Normandy
NCT03662321
National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF
NCT05225441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the second stage, consecutive pathological gamblers seeking treatment at the University Hospital of Nantes completed the three questionnaires.
Only questionnaires from participants who reported gambling at least one time in the past year were kept for analyses.
Responses of students gamblers and pathological gamblers presenting for treatment have been compiled for analysis.
The main objective of the study is to validate the French adaptations of the GABS and the GRCS, and to explore their psychometric properties and structures.
The recruitment period for the first stage is comprised between March 2008 and August 2008.
The recruitment period for the second stage started in September 2008.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
students from the University of Nantes
To be more than 18 years old (the legal age to gamble in France)
Filling of three questionnaires
The only intervention of the study was the completion of the three questionnaires, and of a mini-questionnaire assessing gender, age, and gambling activities.
pathological gamblers seeking treatment
To be more than 18 years old (the legal age to gamble in France)and pathological gambler
Filling of three questionnaires
The only intervention of the study was the completion of the three questionnaires, and of a mini-questionnaire assessing gender, age, and gambling activities.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Filling of three questionnaires
The only intervention of the study was the completion of the three questionnaires, and of a mini-questionnaire assessing gender, age, and gambling activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie Grall-Bronnec, MD
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08/3-F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.